REVVITY, INC Income Tax Expense (Benefit), Intraperiod Tax Allocation
REVVITY, INC (RVTY) reported Income Tax Expense (Benefit), Intraperiod Tax Allocation of $26.26 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitIntraperiodTaxAllocation · last filed 2026-02-24
- REVVITY, INC income tax expense (benefit), intraperiod tax allocation for the quarter ending 2021-01-03 was $92.65M, a 11554.59% increase year-over-year.
- REVVITY, INC income tax expense (benefit), intraperiod tax allocation for the quarter ending 2020-10-04 was $57.06M, a 1115.03% increase year-over-year.
- REVVITY, INC income tax expense (benefit), intraperiod tax allocation for the quarter ending 2020-07-05 was $27.66M, a 909.67% increase year-over-year.
- REVVITY, INC income tax expense (benefit), intraperiod tax allocation for the quarter ending 2020-04-05 was $1.02M, a 24.32% decline year-over-year.
- REVVITY, INC income tax expense (benefit), intraperiod tax allocation for fiscal 2025 was $26.26M, a 29.40% increase from fiscal 2024.
- REVVITY, INC income tax expense (benefit), intraperiod tax allocation for fiscal 2024 was $20.29M, a 92.29% decline from fiscal 2023.
- REVVITY, INC income tax expense (benefit), intraperiod tax allocation for fiscal 2023 was $263.36M, a 68.54% increase from fiscal 2023.
- REVVITY, INC income tax expense (benefit), intraperiod tax allocation for fiscal 2023 was $156.26M, a 53.59% decline from fiscal 2022.
| Period end | Income Tax Expense (Benefit), Intraperiod Tax Allocation 3 month | Income Tax Expense (Benefit), Intraperiod Tax Allocation 6 month | Income Tax Expense (Benefit), Intraperiod Tax Allocation 9 month | Income Tax Expense (Benefit), Intraperiod Tax Allocation 12 month |
|---|---|---|---|---|
| 2025-12-28 | $26.26M 10-K · filed 2026-02-24 | |||
| 2024-12-29 | $20.29M 10-K · filed 2026-02-24 | |||
| 2023-12-31 | $263.36M 10-K · filed 2026-02-24 | |||
| 2023-01-01 | $156.26M 10-K · filed 2025-02-25 | |||
| 2022-01-02 | $336.73M 10-K · filed 2024-02-27 | |||
| 2021-01-03 | $92.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $149.71M derived: sum of 2 quarters · filed 2023-03-01 | $177.38M derived: sum of 3 quarters · filed 2023-03-01 | $178.40M 10-K · filed 2023-03-01 |
| 2020-10-04 | $57.06M 10-Q · filed 2020-11-10 | $84.72M derived: sum of 2 quarters · filed 2020-11-10 | $85.75M 10-Q · filed 2020-11-10 | $86.54M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-07-05 | $27.66M 10-Q · filed 2020-08-11 | $28.69M 10-Q · filed 2020-08-11 | $29.48M derived: sum of 3 quarters · filed 2022-03-03 | $34.18M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-04-05 | $1.02M 10-Q · filed 2020-05-12 | $1.82M derived: sum of 2 quarters · filed 2022-03-03 | $6.51M derived: sum of 3 quarters · filed 2022-03-03 | $9.26M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-29 | $795.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $5.49M derived: sum of 2 quarters · filed 2022-03-03 | $8.23M derived: sum of 3 quarters · filed 2022-03-03 | $9.58M 10-K · filed 2022-03-03 |
| 2019-09-29 | $4.70M 10-Q · filed 2020-11-10 | $7.44M derived: sum of 2 quarters · filed 2020-11-10 | $8.79M 10-Q · filed 2020-11-10 | $16.93M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-30 | $2.74M 10-Q · filed 2020-08-11 | $4.09M 10-Q · filed 2020-08-11 | $12.23M derived: sum of 3 quarters · filed 2021-03-02 | $13.41M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-31 | $1.35M 10-Q · filed 2020-05-12 | $9.49M derived: sum of 2 quarters · filed 2021-03-02 | $10.68M derived: sum of 3 quarters · filed 2021-03-02 | $17.77M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-30 | $8.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $9.32M derived: sum of 2 quarters · filed 2021-03-02 | $16.42M derived: sum of 3 quarters · filed 2021-03-02 | $18.90M 10-K · filed 2021-03-02 |
| 2018-09-30 | $1.19M 10-Q · filed 2019-11-05 | $8.28M derived: sum of 2 quarters · filed 2019-11-05 | $10.76M 10-Q · filed 2019-11-05 | $132.21M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-07-01 | $7.09M 10-Q · filed 2019-08-06 | $9.57M 10-Q · filed 2019-08-06 | $131.03M derived: sum of 3 quarters · filed 2020-02-25 | $144.79M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-04-01 | $2.48M 10-Q · filed 2019-05-07 | $123.93M derived: sum of 2 quarters · filed 2020-02-25 | $137.70M derived: sum of 3 quarters · filed 2020-02-25 | $181.69M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $121.45M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $135.22M derived: sum of 2 quarters · filed 2020-02-25 | $179.21M derived: sum of 3 quarters · filed 2020-02-25 | $184.35M 10-K · filed 2020-02-25 |
| 2017-10-01 | $13.77M 10-Q · filed 2018-11-06 | $57.76M derived: sum of 2 quarters · filed 2018-11-06 | $62.90M 10-Q · filed 2018-11-06 | $70.90M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-07-02 | $43.99M 10-Q · filed 2018-08-07 | $49.13M 10-Q · filed 2018-08-07 | $57.13M derived: sum of 3 quarters · filed 2019-02-26 | $69.60M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-04-02 | $5.14M 10-Q · filed 2018-05-08 | $13.14M derived: sum of 2 quarters · filed 2019-02-26 | $25.61M derived: sum of 3 quarters · filed 2019-02-26 | $27.54M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-01-01 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $20.47M derived: sum of 2 quarters · filed 2019-02-26 | $22.41M derived: sum of 3 quarters · filed 2019-02-26 | $32.62M 10-K · filed 2019-02-26 |
| 2016-10-02 | $12.47M 10-Q · filed 2017-11-07 | $14.40M derived: sum of 2 quarters · filed 2017-11-07 | $24.61M 10-Q · filed 2017-11-07 | |
| 2016-07-03 | $1.94M 10-Q · filed 2017-08-08 | $12.15M 10-Q · filed 2017-08-08 | ||
| 2016-04-03 | $10.21M 10-Q · filed 2017-05-09 | |||
| 2016-01-03 | $31.56M 10-K · filed 2018-02-27 | |||
| 2014-12-28 | $6.61M 10-K · filed 2017-02-28 | |||
| 2013-12-29 | -$15.69M 10-K · filed 2016-03-01 | |||
| 2012-12-30 | -$16.95M 10-K · filed 2015-02-24 | |||
| 2012-01-01 | $58.70M 10-K · filed 2012-02-28 | $58.70M 10-K · filed 2014-02-25 | ||
| 2011-01-02 | $123.64M 10-K · filed 2013-02-26 | |||
| 2010-01-03 | $30.01M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |